Get started

Biotechology

ETON Biotech Big Earning Beat Pullback LONGETON jumped on a big earnings report a week ago. This small cap biotechology company is making big money and traders responded. It has now experienced a standard 0.5 Fib level retracement pullback and traders early in the jump take profit. At this level new buyers have equilibrated with those selling their shares and taking profit. The ZL MACD lines are ready to cross bearly under the histogram whose negative/ red amplitude is reverting toward the zero line. The lines of the dual time frame RS indicator have held above the 50 level. In consideration of this healthy pullback and buying /selling pressure equilibrium I will take a long trade looking for 15-20% upside considering also the uprising fundamentals of the stock based on the big earnings beat.
NASDAQ:ETONLong
by AwesomeAvani
8
VAXX Biotech Penny Stock Earnings Play VAXX is a speculative penny biotechnology NASDAQ stock with high volatility. On the 2H chart, it is currently trending up from a swing low on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm the bullish bias, VAXX is currently trading above its intermediate-term POC line on the volume profile. This confirms buyers as being in control. Although this is speculative as are all biotechnology penny stocks, impending earnings as a catalyst has been considered. Continued development in the vaccine subsector at large may suggest VAXX may have a favorable report to fuel further price action.
VLong
by AwesomeAvani
ACHV Biotech ACHV had good earnings in mid-March and has been in an ascending triangle since that time. The uptrend had a correction April 17th to 20th to which buyers responded with spiking buying volume. Current volume is 3x relative to the usual and customary historical volume averages. I will take a long trade on this when price descends to the support trendline as notified by an alert set on Tradingview. The target is the post covid highs of $ 17.00 . This is modest compared with the average upside of the analysts of $ 22+ ( see the link below) I will take out a sizeable stock position and also some insurance in the form of a long term put option to manage the risk on the trade.
NASDAQ:ACHVLong
by AwesomeAvani
ACHV preparing to Reverse SHORTACHC previously ran up in a high tight flag pattern in my previous idea. It has been slowly ascending in a narrowing channel. ( ascending wedge) There has been a little push in volume on the indicator as price has approached the upper boundaries of the channel. The average directional index has decreased into the " chop zone" where consolidation and lack of direction describes the price action. I see this an an opportunity for a short entry. I will watch things on the 1 and 5 minute charts for the best entry possible and the ride this volatile biotechnology stock a long as possible.
NASDAQ:ACHVShort
by AwesomeAvani
GOSS Penny Biotechology SHORTGOSS is a biotechnology penny stock without earnings valued based on future earnings potential based on a "pipeline" which is subject to a long timeline of FDA regulation. On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP band and well above the POC line of the long-range volume profile. The RSI indicator is now showing a bearish divergence as the relative strength is weakening. Price has bounced down from the resistance of the line representing two standard deviations above VWAP. The supply / demand zones are indicated by the Indicator applied which is authored by Luxalgo. Price has hit the supply zone lower border and is now in an early reversal. I see this as a swing short trade also played with taking put options. Stop loss is in the upper area of the red supply zone. Targets include first the POC line of the volume profile and then a final target at one STD below VWAP also being just above the demand zone. Alternatively put options at the strike of $ 1.50 for the May monthly expiration of 5/18 This trade will benefit from any expected pullback in the general markets.
NASDAQ:GOSSShort
by AwesomeAvani
LABD 3X BEAR BIOTECH LONG DAYTRADEAs shown on the 15-minute chart, LABD is bouncing between stardard deviations of the VWAP in a 6% price range fluctuation day to day. At the upper end it is reversing at the POC of the volume profile confluent with one standard deviation above VWAP while at the bottom it is bouncing from the bottom of the lower high volume area of the profile and two standard deviations below VWAP. I see this as an opportunity for a 6% upside long day trade especially if the general market is uptrending after the weekend. Alternatively, a 5 DTE call option with a strike of $ 15.50 or $16.00 looking for a 30-40% return on the premium over the upcoming week. ( The zero lag MACD confirms the buy signal.)
AMEX:LABDLong
by AwesomeAvani
PBYI a speculative biotech LONGPBYI according to the recent earnings as no earnings nor revenue. This is typical in the biotechnology sector. This 4H chart shows a consistent downtrend with a couple of minor pullback corrections shown with a Doji followed by a green engulfing candle but with low volume and the K/D lines of the MACD did not on the histogram. In the present, the volume pattern shows relatively high selling volume then reversed to buying volume which is above the moving 50 period average shown as the green horizontal line. Moreover, in this episode, the MACD/Signal lines have crossed and curled up. The histogram has sent positive after being negative since early February. I interpret this as being an early reversal now ripe for entry. Just like in nature, the early bird gets the worm. Buyer beware biotechnology stocks that have market cap based on high potentials are speculative but potentially offer high rewards. I see a reasonable target as a 50% retracement of the downturn or about $ 3.50 ( this is less than the upside of some analysts ) PGYI is up 10% today. the train is leaving the station with momentum. I see a potential takeover or a low float short squeeze. (See also the link below )
NASDAQ:PBYILong
by AwesomeAvani
LABU 3X LEVERAGED BIOTECH ETF on support for LONGAMEX:LABU LABU a 3x leveraged EFT in the biotechnology sector has diverse holdings. My thesis is that biotechnology and healthcare are relatively unhinged from the broader general market. On this 15 minute chart, consolidation at support is seen in July, Price then rapidly rose into a triple top in mid-August followed by a descent into a double bottom at the support level. This is a leveraged ETF with good volatility which can be traded. The volume profile of July through mid-August sets a POC as 8,65. This is the best support level within the zone. In the same fashion the volume profile of mid-August through the present sets a POC at 12.45 which is the bottom of the resistance zone. The spread is approximately 40% upside over perhaps two weeks of the expectant uptrend. The zero-lag SMA / EMA oscillator is showing green at its most recent print with an uptrend noted. I will take a trade in a call option with a strike 20 % higher than current price given the potential immediate upside of 40%. I will select an expiration in 4-6 weeks and hope for a 100-200% return.
AMEX:LABULong
by AwesomeAvani
5